A Pragmatic Approach to Investigating Nosocomial Acquisition of Rare and Emerging Molds

Clicks: 6
ID: 329407
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #175 of 176 articles by views in medical mycology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 176 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Invasive mold disease is associated with high mortality in immunosuppressed patients. While Aspergillus spp. and the Mucorales are well known, several other molds have emerged that cause infections and even outbreaks in susceptible hosts. These include Fusarium spp., Scedosporium spp., Lomentospora prolificans, and several others. The principles of preventing nosocomial mold infections include use of high-efficiency particulate air filters, removal of any potential sources of contamination, and risk-assessment of construction sites in adjacent areas. However, there is limited information on the approaches to assessment and management of outbreaks when there is a cluster of rare mold infections. The incubation period of rare and emerging molds is unknown and ascertaining whether the origin is nosocomial or community-acquired is difficult. Surveillance may be required to determine whether cases are part of an ongoing problem. The environmental niches of the rare molds are unique; e.g., Fusarium spp. are associated with hospital water distribution systems. They also cause outbreaks of fungal keratitis. Many rare molds are seen in cases of medicinal product contamination and managing such outbreaks requires support from and coordination by national agencies. Environmental precautions around patients and construction activities should be reassessed during outbreaks. A systematic approach is required when evaluating a cluster or even an isolated nosocomial case. Surveillance systems should be strengthened. This review summarizes the information available on outbreaks of rare and emerging molds. We further discuss a set of actions that may be undertaken in the event of an outbreak.
Reference Key
openalex_W7214011681 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Anuradha Chowdhary, FABIANNE Carlesse, Linda Bagrade, Eelco F J Meijer, Gordon Ramage, Anuradha Chowdhary, Juliëtte A. Severin, Andreas Voss, Thomas J Walsh, Abhijit M. Bal
Journal medical mycology
Year 2026
DOI
10.1093/mmy/myag103
URL
https://doi.org/10.1093/mmy/myag103
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.